Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

cyclopia sequence 10Lung Neoplasms 3Pain 2Neoplasms, Plasma Cell 2Multiple Myeloma 2Head and Neck Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Breast Neoplasms 2Sleepiness 1Peripheral Nervous System Diseases 1Parasomnias 1Pancreatic Neoplasms 1Oropharyngeal Neoplasms 1Neoplasm Metastasis 1Laryngeal Diseases 1Hypesthesia 1Glioma 1Fatigue 1Exanthema 1Esophageal Neoplasms 1Depression 1Colorectal Neoplasms 1Carcinoma 1Anxiety Disorders 1Anorexia 1Acute Pain 1

Interventions

Gemcitabine 43pembrolizumab 36Paclitaxel 36Nivolumab 31Docetaxel 29Capecitabine 29Bevacizumab 29Oxaliplatin 28Fluorouracil 28Cisplatin 26Leucovorin 24Cyclophosphamide 23Radiosurgery 20Irinotecan 20Carboplatin 20aldesleukin 19Cetuximab 19Interleukin-2 16fludarabine phosphate 15fludarabine 15Pemetrexed 15Trastuzumab 14Magnetic Resonance Spectroscopy 14Ipilimumab 14Fulvestrant 14130-nm albumin-bound paclitaxel 14Prednisone 13Everolimus 13Radiotherapy 12Panitumumab 12

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Neoplasm Metastasis × Minocycline × Clear all
NCT01693523 2020-03-09

Minocycline Study in Pancreatic Cancer Patients

M.D. Anderson Cancer Center

Phase 2 Completed
80 enrolled 10 charts
Gastrointestinal

cyclopia sequence, Neoplasm Metastasis, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡